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Anyone concerned with cancer research
must have been struck by the gulf which
nearly always divides the clinician treating
patients and the cancer research worker in
his laboratory. One side's view is well put
right at the end of this excellent book:
doctors who treat patients . . . believe
they will gradually find better and better
combinations of drugs for treating more and
more types of cancer and, in this way, will
eventually start to make major inroads into
cancer mortality without having to under-
stand very much about the mechanism under-
lying the origin and spread of the disease."
The cancer research worker, on the other
hand, believes that only a scientific study of
the causation and nature of the different
kinds of cancer cell will lead to rational pre-
ventive and therapeutic measures. He can
reasonably hope that such a treatment will
have fewer side-effects, be cheaper and more
effective than those resulting from empirical
study, but ifhe is honest he will have to admit
that he has no idea now which of the many
lines of current cancer research will give him
his breakthrough.
The great merit of this book is that it
covers shortly and in admirable style nearly
all the major approaches to cancer research.
Starting with the varieties and cellular origins
of cancer, it goes on to cover the complex
epidemiology and environmental factors
affecting the disease. This is followed by an
introduction to current molecular biology and
genetics which lays the foundation for a
major section of the book, which is a survey
of cancer research, considering first, the role
of chemicals, radiation and viruses. Most
emphasis is given to chemical carcinogenesis,
reflecting our current preoccupation with this
subject. The point is made that despite a
100-fold increase in the production of pesti-
cides, plastics and artificial rubber in the
United States in the last 30 years, the inci-
dence ofmost types ofcancer, except that for
the lung, is still falling.
The discussion of viruses in cancer is help-
ful and realistic, reflecting the author's view,
however, that viruses are probably not
important for the naturally occurring cancers
of man, but nevertheless are important in
their own right as experimental systems for
the study of carcinogenesis.
The second part of the survey of cancer
research is concerned with the properties of
normal and malignant cells. The discussion of
the differences between them at both the
histological and the cellular level reflects
rather a pessimistic view about our current
ability to identify cellular differences suffici-
ently large to be exploited therapeutically,
but this is still the area which has greatest
potential.
Finally, the author considers the time
course of cancer, its often long latent period,
its several intermediate clinical stages, and
returns to the theme derived earlier from
epidemiology, that there must be several
steps in the development of the disease. One
of these must involve, almost invariably, a
change in the genetic level (in the DNA) but
the other steps may occur elsewhere and pro-
vide different possibilities for intervention.
This is a humane and scholarly book; short,
at less than 200 pages, and, for these days,
very cheap. It is well illustrated and each
chapter is provided with references for further
reading. It can be recommended to both
medical students and to cancer research
workers. Most of it should be readily under-
stood by the educated layman concerned
about cancer. It is compulsory reading for all
pressure groups in the cancer field.
P. M. B. WALKER
Hodgkin's Disease and the Lymphomas,
Vol. 3 (Ann. Res. Reviews). Ed. C. R.
TAYLOR (1979): Chuirchill Livingstone. 437 pp.
£16.50.
Clive Taylor opens this review by stating
that it is directed towards assisting the histo-
logist to understand the immunologist, the
immunologist to communicate with the
histologist, and the clinician to interpret theBOOK REVIEWS 671
histologist's report and the immunologist's
functional finding. This is a mammoth task
when one realises that there were over 1500
references to be reviewed in the 1977 litera-
ture alone. It is not surprising, therefore, that
in this, his 3rd annual review, Clive Taylor
has invited other workers from the University
of California to assist.
The subject matter covers a wide range of
conditions which may be considered to fall
under the general heading of malignant
lymphoma, including lymphocytic leukaemias
and myeloma. The first third of the review
deals with surface marker, ultrastructure,
cytochemistry, genetic and kinetic studies of
lymphoid malignancies. The rest ofthe review
deals in detail with the pathological and
clinical aspects ofthe different disease groups.
The authors are to be congratulated that the
subjects are dealt with in a clear, easily read-
able style rather than a simple list of refer-
ences. Despite the high quality of the re-
viewers, after reading the chapter on the
pathologic classification of non-Hodgkin's
lymphoma, I felt that the quote of R. Willis
(1948) which opened Chapter 1 was still true:
"Nowhere in pathology has a chaos ofnames
so clouded clear concepts as in the subject of
lymphoid tumours".
Research workers and clinicians alike will
find this a valuable review of a difficult
subject.
J. H. SCARFFE
Breast Cancer. Advances in Research and
Treatment. Vol. 3-Current Topics.
Ed. W. L. McGUIRE (1979) New York:
Plenum Publishing Corp. 271pp. $39 50.
This is the third book in this series covering
all aspects of breast cancer; its subtitle
"Current Topics" aptly describes the range
ofcontributions to the book, and the chapters
are all written by experts in their particular
field. The authors give lucid evaluations ofthe
present state ofresearch intothebasic biology
of breast cancer and into modem techniques
ofassessment and treatment ofthe disease.
There are chapters on the factors in-
fluencing metastasis and on mechanisms of
tumour regression. Much attention is paid to
the effect of the hormone environment on the
natural history of the disease, in both males
and females. All are intriguing, as they pose
as many questions as they answer and they
pin-point avenues of future research.
The position of steroid-receptor analysis in
the assessment of breast cancer is well estab-
lished, and the chapter by the editor of this
book, Bill McGuire and his co-worker Gary
Chamness, gives a clear summary ofthe assay
methods available, and some of the pitfalls
that may be encountered by newcomers to
the field.
There is an interesting chapter on mam-
mography which summarizes the recent re-
ports on the risks and benefits from the pro-
cedure, and the author emphasizes the factors
that should be considered before launching
into screening programmes.
The real value of the book is that it has
been written by people actively involved in
their particular area of breast-cancer re-
search. Each author gives a comprehensive
literature survey and builds on that back-
ground to highlight the direction in which
they think that research should proceed in
the future.
D. BARNES
Carcinogenic Risks: Strategies for Inter-
vention. Proceedings of a Symposium
organised by IARC and l'Institut National
de la Sante et de le Recherche Medicale,
1979. Ed. W. DAVIES (1979) WHO.
283 pp. 50 Sw. Fr.
The object of the symposium was to high-
light experiences and problems in this subject
area which spans scientific, legislative and
public opinions. The reader is spared a
detailed description of legislative actions in
various countries, although sufficient infor-
mation is provided to give a flavour of the
legislative approach in France, Finland,
Sweden, the U.K. and U.S.A.
The proceedings of the symposium consist
of 25 papers organized into an introduction,
5 sections and a summing up, with each
section carrying a discussion summary. The
5 sections, on smoking, occupational risks,
food additives, drugs and pesticides, measure-
ment of carcinogenic risk and strategies of
intervention, use some of the problems and
paradoxes in the control of carcinogenic risks
to illustrate its complexity. A welcome
feature is the attempt by some speakers to
identify the role of scientists as those re-
sponsible for providing data which should be